Cleared Traditional

K160605 - MectaLIF Anterior Stand-Alone

K160605 is the FDA 510(k) clearance for MectaLIF Anterior Stand-Alone by Medacta International. It is a Class 2 Orthopedic device (product code OVD) cleared through the Traditional 510(k) pathway after a 141-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2016
Decision
141d
Days
Class 2
Risk

K160605 is an FDA 510(k) clearance for the MectaLIF Anterior Stand-Alone. Classified as Intervertebral Fusion Device With Integrated Fixation, Lumbar (product code OVD), Class II - Special Controls.

Submitted by Medacta International (Castel San Pietro, CH). The FDA issued a Cleared decision on July 21, 2016 after a review of 141 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Medacta International devices

Submission Details

510(k) Number K160605 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 02, 2016
Decision Date July 21, 2016
Days to Decision 141 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 122d · This submission: 141d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Lumbar Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Medacta USA
Roshana Ahmed

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar

All 148
Devices cleared under the same product code (OVD) and FDA review panel - the closest regulatory comparables to K160605.
ELSA Spacers
K161379 · Globus Medical, Inc. · Sep 2016
PILLAR SA PTC
K161129 · Orthofix, Inc. · Sep 2016
INDEPENDENCE MIS Spacers
K160597 · Globus Medical, Inc. · Aug 2016
TransContinental® M Spacers and InterContinental® Plate-Spacers
K161223 · Globus Medical, Inc. · Jul 2016
NuVasive® Interfixated Interbody System
K160051 · Nu Vasive, Incorporated · Apr 2016
Sahara Stabilization System
K151481 · K2m, Inc. · Dec 2015